$400m US Private Placement

Spectris PLC
11 November 2024
 

11 NOVEMBER 2024

 

SPECTRIS PLC

 

$400m US Private Placement

 

Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces the successful completion of a $400m issue of US Private Placement ("USPP") notes, following a competitive process.

The issuance, on investment grade terms, refinances the $400m bridge facility that was entered into for acquisition purposes. The USPP debt comprises USD and EUR tranches with maturities between 5 and 10 years, issued at average rates of 5.15% for USD and 3.66% for EUR.

END

 

Contacts:

 

Spectris plc

 

Mathew Wootton

Investor Relations Director

+44 7500 078 880

 

Teneo

Martin Robinson/Giles Kernick

+44 20 7353 4200

 

About Spectris

Spectris combines precision with purpose, delivering progress for a more sustainable world. We provide critical insights to our customers through premium precision measurement solutions combined with technical expertise and deep domain knowledge. Precision is at the heart of what we do - our leading, high-tech instruments and software equip our customers to solve some of their greatest challenges to make the world cleaner, healthier and more productive. We are focused on two key divisions - Spectris Scientific and Spectris Dynamics, which are placed in technology-driven end markets, with strong fundamentals and attractive growth trajectories. We have leading market positions in premium segments and employ 7,600 people located in more than 30 countries, all united behind our purpose to deliver value beyond measure for all our stakeholders. For more information, visit www.spectris.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Spectris (SXS)
UK 100

Latest directors dealings